Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Cachexia, Sarcopenia and Muscle|March 19, 2024
Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study designJohn D Groarke, Jeffrey Crawford, Susie M Collins, et al.World Journal of Surgical Oncology|September 21, 2018
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of boneJacob Engellau, Leanne Seeger, Robert Grimer, et al.The Canadian Journal of Cardiology|March 10, 2015
Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devicesLiza Grosman-Rimon, Ira Jacobs, Laura C Tumiati, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 19, 2014
Markers of inflammation in recipients of continuous-flow left ventricular assist devicesLiza Grosman-Rimon, Michael A McDonald, Ira Jacobs, et al.Nutrients|April 13, 2023
Indirect Calorimetry to Measure Metabolic Rate and Energy Expenditure in Psychiatric Populations: A Systematic ReviewJoshua Daniel Di Vincenzo, Liam O'Brien, Ira Jacobs, et al.The Lancet. Oncology|July 23, 2013
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 studySant Chawla, Robert Henshaw, Leanne Seeger, et al.Acta Oncologica (Stockholm, Sweden)|May 20, 2014
Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II studyJavier Martin-Broto, Charles S Cleeland, Paul A Glare, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 studyGiorgio Vittorio Scagliotti, Vera Hirsh, Salvatore Siena, et al.European Journal of Cancer (Oxford, England : 1990)|September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.Pageof 8